Volume 22, Number 2—February 2016
Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015
|Patient no., date of symptom onset||Sample type||Date of sample collection||Cycle threshold for upE/ORF1a||Transmission generation (source of transmission)|
|14, May 25||Second (patient 1 to 14)|
|Sample 1||ETA||May 31||24.0/25.2|
|35, May 29||Third (patient 1 to 14 to 35)|
|Sample 1||Sputum||Jun 3||24.7/25.3|
|168, June 17||ETA||Fourth (patient 1 to 14 to 76 to 168)|
|Sample 1||Sputum||Jun 21||31.6/32.3|
|163, June 13||Fourth or fifth (patient 1 to ? to 52 to 119 to 163)|
|Sample 1||Sputum||Jun 19||20.2/20.9|
|Sample 2||Sputum||Jun 29||28.4/28.8|
*ETA, endotracheal aspirate; MERS-CoV, Middle East respiratory syndrome coronavirus; ORF1a, open reading frame 1a gene; upE, upstream of E gene.
1These authors contributed equally to this article.
Page created: January 15, 2016
Page updated: January 15, 2016
Page reviewed: January 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.